ALZAMEND NEURO, INC.

Consensus Alzamend Neuro, Inc.

Stocks

ALZN

US02262M6057

Biotechnology & Medical Research

Market Closed - Nasdaq 07:30:00 17/10/26 am AEDT			5-day change	1st Jan Change
1.300 ^USD	+1.56%		-2.99%	-28.57%

11/09	Alzamend Neuro, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026	CI
20/08	Alzamend Neuro Reports Resting-State Fmri Findings For Al001 Accepted For Poster Presentation At Neuroscience 2026	CI

Evolution of the Average Target: Alzamend Neuro, Inc.

Evolution of the Average Target - Alzamend Neuro, Inc.

Evolution of the Target Price: Alzamend Neuro, Inc.

Evolution of the Target Price - Alzamend Neuro, Inc.

Changes in Analyst Recommendations: Alzamend Neuro, Inc.

97e593a.hncFwsbZ2T6ZIkstYk5lHJ6BsCFocJR1X41wKZavaFw.6hln84-ugFTwRAd5VzoBJMG3iGUAP9hYDMgIX_DLMirfPnOKnIabDvBAGg~3871173b4125b27110f7188e7276e1ea

Analysts' recommendations: Alzamend Neuro, Inc.

12/04/23	Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target	MT
28/12/21	Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating	MT
02/10/21	Alzamend Neuro : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALZAMEND NEURO, INC.			-	-	+1,900%
	WUXI APPTEC CO., LTD.					+32.97%
	LONZA GROUP AG					+14.74%
	ARGENX SE					+38.45%
	IQVIA HOLDINGS INC.					+12.07%
	BEONE MEDICINES AG					+18.26%
	REVOLUTION MEDICINES, INC.					+44.87%
	CELLTRION, INC.					+38.06%
	WUXI BIOLOGICS (CAYMAN) INC.					+24.78%
	GENMAB A/S					+8.87%
	Average					+213.31%
	Weighted average by Cap.					+26.79%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.300USD

Average target price

26.00USD

Spread / Average Target

+1,900.00%

High Price Target

26.00USD

Spread / Highest target

+1,900.00%

Low Price Target

26.00USD

Spread / Lowest Target

+1,900.00%

Analyst Consensus Detail

Analyst consensus - Alzamend Neuro, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Alzamend Neuro, Inc.

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
ALZN Stock
Consensus Alzamend Neuro, Inc.

The best tools reserved for subscribers to boost the performance of your investments!

×